The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 08, 2009

Filed:

Sep. 20, 2004
Applicants:

Eugene R. Cooper, Berwyn, PA (US);

David M. Kleinman, Rochester, NY (US);

Thierry Nivaggioli, Atherton, CA (US);

Philippe J M Dor, Cupertino, CA (US);

Sreenivasu Mudumba, Union City, CA (US);

Inventors:

Eugene R. Cooper, Berwyn, PA (US);

David M. Kleinman, Rochester, NY (US);

Thierry Nivaggioli, Atherton, CA (US);

Philippe J M Dor, Cupertino, CA (US);

Sreenivasu Mudumba, Union City, CA (US);

Assignee:

Macusight, Inc., Union City, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 2/00 (2006.01); C12P 21/04 (2006.01); A61K 38/00 (2006.01); A61K 31/44 (2006.01); A61K 31/445 (2006.01);
U.S. Cl.
CPC ...
Abstract

Diseases associated with the tissues in the posterior segment of the eye can be effectively treated by administering therapeutic agents transsclerally to those tissues. Compositions, devices, and methods for delivering therapeutic agents so that they cross the sclera and reach these tissues include injecting solutions or suspensions adjacent to or within the sclera and implanting solid structures containing the therapeutic agent adjacent to or within the sclera. These methods may be used for administering rapamycin or related compounds to treat choroidal neovascularization associated with age-related macular degeneration.


Find Patent Forward Citations

Loading…